Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 126

Sort by

Sort Order Select

Journal Articles

Venetoclax with Decitabine as Frontline Treatment for Younger Adults with Newly Diagnosed ELN Adverse-Risk AML

Blood blood.2023020102.

https://doi.org/10.1182/blood.2023020102

Published: 2023

Includes: Supplemental data

Journal Articles

The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease

Qiao Cheng, Dong Wang, Xiaoxuan Lai, Yin Liu, Yibo Zuo, Wenli Zhang, Lei Lei, Jia Chen, Hong Liu, Ying Wang, Haiyan Liu, Hui Zheng, Depei Wu, Yang Xu

Blood (2023) 141 (12): 1474–1488.

https://doi.org/10.1182/blood.2022017201

Published: 2023

Includes: Supplemental data

Journal Articles

Prognostic Effect and Clinical Application of Early Measurable Residual Disease (MRD) By Flow Cytometry on De Novo Acute Myeloid Leukemia (AML)

Congxiao Zhang, Runxia Gu, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Benfa Gong, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Shaowei Qiu, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 2030–2032.

https://doi.org/10.1182/blood-2022-162459

Published: 2022

Journal Articles

Structural Optimization of Dual-Target CD22/CD19 CAR-T and Its Anti-Tumor Effects on B Cell Malignancies

Yu Zhang, Ying Wang, Runxia Gu, Lin Shi, Yongzeng Wang, Yi Feng, Lulu Lv, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 630–631.

https://doi.org/10.1182/blood-2022-162345

Published: 2022

Journal Articles

Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia

Qian Wang, Haiping Dai, Wenzhi CAI, Qinrong Wang, Zhu Mingqing, Lingzhi Yan, Yan Yu, Hongjie Shen, Yang Xu, Ying Wang, Miao Miao, Shengli Xue, Yue Han, Xiaowen Tang, Huiying Qiu, Aining Sun, Jinyan Huang, Depei Wu, Suning Chen

Blood (2022) 140 (Supplement 1): 9198–9200.

https://doi.org/10.1182/blood-2022-156862

Published: 2022

Journal Articles

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial

Jundan Xie, Xiaofei Yang, Xiebing Bao, Hongjie Shen, Jiannong Cen, Li Yao, Xiaohui Hu, Qian Wu, Jingren Zhang, Xuefeng He, Xiaowen Tang, AiNing Sun, Hongchun Qiu, Shengli Xue, Ying Wang, Jianhong Fu, Huiying Qiu, Depei Wu, Suning Chen

Blood (2022) 140 (Supplement 1): 1439–1440.

https://doi.org/10.1182/blood-2022-166384

Published: 2022

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 1598–1600.

https://doi.org/10.1182/blood-2022-165002

Published: 2022

Journal Articles

A Patient-Centered Communication Tool for Older Patients with Acute Myeloid Leukemia, Their Caregivers, and Oncologists: A Single Arm Pilot Study

Marissa Locastro, Chandrika Sanapala, Ying Wang, Marielle Jensen-Battaglia, Marsha Wittink, Sally Norton, Heidi Klepin, Daniel R. Richardson, Jason H. Mendler, Jane L. Liesveld, Eric J. Huselton, Kristen M. O'Dwyer, Ashley-Marie Cortes, Chrystina Rodriguez, Kah Poh (melissa) Loh

Blood (2022) 140 (Supplement 1): 324–325.

https://doi.org/10.1182/blood-2022-165499

Published: 2022

Journal Articles

Association of Noninvasive Peripheral Blood Hemoglobin Assessments with Venous Blood Draws Among Sickle Cell Patients

Sang Mok Park, Yuhyun Ji, Semin Kwon, Andrew RW O'Brien, Ying Wang, Young L Kim

Blood (2022) 140 (Supplement 1): 7832–7833.

https://doi.org/10.1182/blood-2022-165132

Published: 2022

Journal Articles

Acupuncture Alleviates Pain and Improves Quality of Life in Patients with Sickle Cell Disease

Tyler J Barrett, Andrew Pucka, Brandon Reyes, Seethal A Jacob, Andrew RW O'Brien, Richard Harris, Steven Harte, Ying Wang

Blood (2022) 140 (Supplement 1): 5444–5445.

https://doi.org/10.1182/blood-2022-169013

Published: 2022

Journal Articles

Development of a mRNA Lipid Nanoparticle (mRNA-LNP) Cancer Vaccine to Prevent Leukemia Relapse after Stem Cell Transplant

Anson Snow, Lin Lin, Sally A. Hunsucker, Ying Wang, Rihe Liu, Paul M. Armistead

Blood (2022) 140 (Supplement 1): 7382–7383.

https://doi.org/10.1182/blood-2022-160218

Published: 2022

Journal Articles

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

Bo Dai, Feng Wang, Ying Wang, Jiayan Zhu, Yunxuan Li, Tingting Zhang, Luyao Zhao, Li-Ling Wang, Wenhui GAO, Junmin Li, Aibin Liang, Hong-hu Zhu, Ke Li, Jiong Hu

Blood (2022) 140 (Supplement 1): 5924–5925.

https://doi.org/10.1182/blood-2022-156735

Published: 2022

Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3292–3293.

https://doi.org/10.1182/blood-2022-165261

Published: 2022

Journal Articles

Single Tube Molecular Profiling of ALL Samples Reveals Integrated Molecular Signature and Highlights Gene Regulatory Networks

Lina Zelinger, Samuel Koo, Francys Alarcon, Charmeine Ko, Brad B Thomas, Segun C Jung, Ying Wang, Fei Ye, Shashikant Kulkarni

Blood (2022) 140 (Supplement 1): 11870–11871.

https://doi.org/10.1182/blood-2022-166932

Published: 2022

Journal Articles

A Novel Finding in Cerebral Blood Flow in Patients with Sickle Cell Disease Using Bold Functional MRI

Jinxia Yao, Andrew RW O'Brien, Yunjie Tong, Ying Wang

Blood (2022) 140 (Supplement 1): 5433–5434.

https://doi.org/10.1182/blood-2022-167594

Published: 2022

Journal Articles

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells

Leling Xie, Runxia Gu, Xue Yang, Shaowei Qiu, Yingxi Xu, Junli Mou, Ying Wang, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 4535.

https://doi.org/10.1182/blood-2022-158682

Published: 2022

Journal Articles

CD19 Expression by IHC Alone Is Not a Predictor of Response to Loncastuximab Tesirine: Results from the LOTIS-2 Clinical Trial and Quantitative Systems Pharmacology Modeling

Paolo F. Caimi, Mehdi Hamadani, Carmelo Carlo-Stella, Masoud Nickaeen, Eric Jordie, Kiersten Utsey, Tim Knab, Francesca Zammarchi, Serafino Pantano, Karin Havenith, Ying Wang, Joseph Boni

Blood (2022) 140 (Supplement 1): 9548–9550.

https://doi.org/10.1182/blood-2022-159626

Published: 2022

Journal Articles

A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies

Anhthu Dang, Deborah Knee, Cui Ying Wang, Feng Gao, Guoxun Liu, Sergio Briones, Michelle Coulson, Jessica Makofske, Keith Mansfield, May Liu, Tanya Mulvey, Emily K Meseck, Steve Woolfenden, Sean G Buchanan, David Steensma, Vasileios Askoxylakis

Blood (2022) 140 (Supplement 1): 11564–11565.

https://doi.org/10.1182/blood-2022-159910

Published: 2022

Journal Articles

A Phase 1b Open-Label Study of Loncastuximab Tesirine in Combination with Other Anticancer Agents in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (LOTIS-7)

Brian T. Hess, Graham P. Collins, Melhem Solh, Mitul Gandhi, Ying Wang, Yajuan Qin, Eric Yu, Pier Luigi Zinzani

Blood (2022) 140 (Supplement 1): 12079–12080.

https://doi.org/10.1182/blood-2022-163277

Published: 2022

Journal Articles

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Blood (2022) 139 (23): 3376–3386.

https://doi.org/10.1182/blood.2021013733

Published: 2022

Includes: Supplemental data

NARROW

Venetoclax with Decitabine as Frontline Treatment for Younger Adults with Newly Diagnosed ELN Adverse-Risk AML

The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease

Prognostic Effect and Clinical Application of Early Measurable Residual Disease (MRD) By Flow Cytometry on De Novo Acute Myeloid Leukemia (AML)

Structural Optimization of Dual-Target CD22/CD19 CAR-T and Its Anti-Tumor Effects on B Cell Malignancies

Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

A Patient-Centered Communication Tool for Older Patients with Acute Myeloid Leukemia, Their Caregivers, and Oncologists: A Single Arm Pilot Study

Association of Noninvasive Peripheral Blood Hemoglobin Assessments with Venous Blood Draws Among Sickle Cell Patients

Acupuncture Alleviates Pain and Improves Quality of Life in Patients with Sickle Cell Disease

Development of a mRNA Lipid Nanoparticle (mRNA-LNP) Cancer Vaccine to Prevent Leukemia Relapse after Stem Cell Transplant

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Single Tube Molecular Profiling of ALL Samples Reveals Integrated Molecular Signature and Highlights Gene Regulatory Networks

A Novel Finding in Cerebral Blood Flow in Patients with Sickle Cell Disease Using Bold Functional MRI

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells

CD19 Expression by IHC Alone Is Not a Predictor of Response to Loncastuximab Tesirine: Results from the LOTIS-2 Clinical Trial and Quantitative Systems Pharmacology Modeling

A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies

A Phase 1b Open-Label Study of Loncastuximab Tesirine in Combination with Other Anticancer Agents in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (LOTIS-7)

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only